Analysis of Risk Factors for Death from Melanoma and Genitourinary Diseases in Male Patients with Cutaneous Melanoma: A Cohort Propensity Score Matching Study

Kaijie Wang,Weiwei Wu,Yongbao Wei,Xianwei Cao

DOI: https://doi.org/10.2147/ccid.s482389

2024-10-22

Clinical Cosmetic and Investigational Dermatology

Abstract:Kaijie Wang, 1 Weiwei Wu, 2 Yongbao Wei, 3 Xianwei Cao 1 1 Department of Dermatology, the 1st affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China; 2 Department of Neurology, Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China; 3 Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, People's Republic of China Correspondence: Xianwei Cao; Yongbao Wei, Email ; Objective: To analyze the influencing factors of male cutaneous melanoma (CM) patients dying from genitourinary diseases (GUD). Methods: We searched the surveillance, epidemiology, and end results (SEER) database and extracted data on male CM patients according to the inclusion and exclusion criteria, including male patients whose cause of death was CM (cohort A) or GUD (cohort B). Comparisons between the two cohorts were performed before and after propensity score matching (PSM). An interaction analysis between age and year of diagnosis was also conducted. Cox regression analysis were performed to find the risk factors for death from GUD. Results: Seven thousand seventy-eight CM patients were included, including 6415 (90.6%) in cohort A and 663 (9.4%) in cohort B. Compared with cohort A, cohort B patients were older (median age 74 ys. vs 65 ys.) and were more under the localized stage and had longer survival time no matter before or after PSM (all p< 0.001). The stage was an inhibitory factor for cohort B (p < 0.001). After PSM, only age and year of diagnosis were found to be cohort B's promoting factors (p< 0.001). The interaction analysis showed that older patients diagnosed in later years (2009– 2020) had a higher risk of dying from GUD compared to those diagnosed earlier (p< 0.05). Patients with a later year of diagnosis (2009– 2020) had a lower median survival time than patients with an earlier year of diagnosis (2000– 2008) (p 75 ys.) had a higher risk of dying from GUD than younger patients (≤ 75 ys.) (p< 0.001). Conclusion: We first reported a significant interaction between age and year of diagnosis in male CM patients dying from GUD, highlighting the increased risk in older patients diagnosed more recently. We may pay attention to the possibility of dying from genitourinary diseases for CM patients. Keywords: cutaneous melanoma, genitourinary diseases, non-cancer mortality, genitourinary cancer, cohort study Cutaneous melanoma (CM), the third most common skin cancer, is a malignant melanocytic tumor associated with poor survival and extremely high mortality. 1,2 The annual incidence of CM in Europe ranges from 3.5/100,000 in Mediterranean countries to 12–35/100,000 in Nordic countries. 1 Mortality and morbidity rates increased in Eastern European countries compared with Western European countries. 3 Although any age can be affected, studies have found that melanoma incidence peaks at age 65, posing a severe threat to the survival of older adults. 1 CM is also one of the cancers with the fastest incidence rate in China; its net annual incidence rates for men and women were 3.523% and 3.779%, respectively. 4 With the global aging process, more and more older adults may suffer from CM. 5 CM is a fatal cancer; thus, such patients' leading cause of death is CM, especially patients with advanced CM, and people may ignore that CM may die from other systemic diseases. 1,6 Genitourinary diseases (GUD) in CM patients are often overlooked, which may negatively impact the comprehensive management of these patients. In our clinical experience, a number of CM patients face complications related to renal or bladder neoplastic diseases, or renal functional disorders, which pose challenges in managing CM and may directly or indirectly affect the survival of these patients. In addition, there is a rare but clinically aggressive form of primary melanoma of the genitourinary tract that has been documented in the past decades. 7 While this form of melanoma is not common, its existence further emphasizes the importance of investigating the connection between CM and GUD, particularly in understanding its impact on patient outcomes. There were very few studies on the specific causes of death of CM patients, especially on deaths from other systemic diseases; for example, studies on CM patients dying from GUD have not been reported. 1,2,8 This study would analyze the influencing factors of male CM patients dy -Abstract Truncated-

dermatology